02-Sep-15 The Chinese Food and Drug Administration has approved the use of 3D printed hip implants, which fall into the highest regulated group of medical devices in the country. The approval is expected to be a major breakthrough for 3D printing technology within the medical field. The technology will help in lowering costs. [image: 3ders]

08-Jul-15 Emerging markets are the medtech industry’s best prospects for growth, but most medical devices are still designed in the US and Europe. That can present a problem when companies try to adapt devices or develop new devices for non-Western markets, which may have different cultural, financial, and other considerations that can affect the success of a product. [image: University of Minnesota]

04-Sep-15 Korean medical companies will speed up their entry into China, having secured a bridgehead into the telemedicine market by inking agreements with Chinese partners. Other agreements will allow Korea to export more drugs and biotech to China. These developments will help Korea become one of the top seven healthcare powers within five years. [image: Business Korea]

02-Sep-15 China's economic downturn plus other factors, including overcapacity and tightening regulations, mean the next two to three years could be challenging for the foreign chemical and pharmaceutical companies located there. [image: Want China Times]

23-Aug-15 Emerging-market sales for the big pharmaceuticals firms increased by about 5.5% year over year in the second quarter, well below the 9% average of the prior four quarters. Macroeconomic pressures are increasing. Weaker currencies hurt sales, a factor put into clear focus by China’s devaluation of the yuan. [image: Nai 500]